Lipoatrophy secondary to human insulin treatment. Immunological study.
Igea
J M
JM
Servicio de Alergia, Hospital Ramón y Cajal, Madrid, Spain.
Escalada
J
J
Cuevas
M
M
Sainz
T
T
Barrio
R
R
D002446:Celiac Disease / Q000150:complications; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007328:Insulin / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D007330:Insulin Antibodies / Q000032:analysis; D008060:Lipodystrophy / Q000139:chemically induced* / Q000276:immunology
D007074:Immunoglobulin G; D007328:Insulin; D007330:Insulin Antibodies